Lianyungang, China

Xiangjian Wang


 

Average Co-Inventor Count = 8.3

ph-index = 1


Location History:

  • Lianyungang, CN (2020 - 2022)
  • Jiangsu, CN (2023)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations and Contributions of Inventor Xiangjian Wang

Introduction

Xiangjian Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic combinations for cancer treatment. With a total of four patents to his name, Wang's work is paving the way for advancements in medical therapies.

Latest Patents

Wang's latest patents include a therapeutic combination of a quinoline derivative and an antibody. This innovative application provides a combination that includes an immune checkpoint inhibitor and a tyrosine kinase inhibitor, demonstrating good activity against lung and liver tumors. Another significant patent involves a quinoline derivative specifically designed for the treatment of triple-negative breast cancer. This invention outlines the use of a particular quinoline derivative in preparing a pharmaceutical composition aimed at treating tumors.

Career Highlights

Throughout his career, Xiangjian Wang has worked with prominent companies in the pharmaceutical industry. Notable among these are Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc. His work in these organizations has contributed to the development of effective cancer treatments.

Collaborations

Wang has collaborated with esteemed colleagues, including Xin Tian and Xiquan Zhang. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Xiangjian Wang's innovative contributions to cancer treatment through his patents and collaborations highlight his importance in the field of pharmaceuticals. His work continues to inspire advancements in medical therapies that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…